Boost Your Health With Alivia 

This product is a powerful, dual-action injection combining two peptides that work synergistically. CJC-1295 is the "sustainer," which acts as a Growth Hormone Releasing Hormone (GHRH) to prolong and amplify the amount of Growth Hormone (GH) released. Ipamorelin is the "pulse," a Growth Hormone Secretagogue (GHS) that triggers a rapid, natural pulse of GH release. When combined, the two peptides create a strong, stable, and natural increase in GH levels. This results in benefits like increased muscle mass, enhanced fat burning, better recovery, and significantly deeper, more restorative sleep.

The goal is to align the injection with your body's natural GH production cycle, which peaks during deep sleep.

Instruction: Injection Site - Administer via subcutaneous (SC) injection (into the fatty tissue) of the abdomen, thigh, or upper arm. Rotate the injection site daily.

Timing: Once daily, just before bed, on an empty stomach. This means waiting at least 60-90 minutes after your last meal, as food (especially carbohydrates) can blunt the release of Growth Hormone.

Syringe: Use a new, sterile insulin syringe (typically 29-31 gauge).

Storage: Refrigerate the vial after mixing (reconstitution) and keep it refrigerated. Do not freeze or shake the vial.

Duration: A typical course lasts 8 to 12 weeks, followed by a break as prescribed by your doctor.

The first result most users notice is significantly improved sleep quality within the first few weeks. Noticeable changes in body composition, energy, and recovery generally begin around 4-6 weeks and continue to build over the full 3-6 month period.

No. This blend stimulates your body to produce its own natural Growth Hormone in a pulsatile (bursting) pattern, which is considered safer and more balanced than injecting synthetic HGH, which can suppress your body's natural production.

Side effects are generally mild and temporary. The most common include injection site reactions (redness, itching, mild pain), temporary water retention (puffiness in hands or feet), a mild headache or flushing after injection, and sometimes increased hunger (from Ipamorelin's Ghrelin-mimicking action).

No. Both CJC-1295 and Ipamorelin are classified as Prohibited Substances by the World Anti-Doping Agency (WADA) due to their performance-enhancing effects. Tested athletes must avoid this blend.